Aytu BioPharma sells prescription medicines for depression, ADHD and allergic conditions from its base in Denver, Colorado. It last closed at $2.66 on Nov 17, up 47.78% on the day. AYTU reports earnings on Tue, Feb 2, 2027. The average 12-month price target from 2 analysts is $8.85 (+232.7% from the last close), with a high of $15.00 and a low of $2.70.
Only 2 firms rated AYTU in the past 90 days, not enough for a consensus
Average 12-month target
$8.85
▲ 232.7% upside
Based on 2 analysts who set a price target on AYTU in the past 90 days. The average target is $8.85, with a high of $15.00 and a low of $2.70, compared with the last close of $2.66.
Low $2.70Avg $8.85High $15.00
Blue marker: last close $2.66
Highest target$15.00
Average target$8.85
Lowest target$2.70
Latest rating changes
Lake StreetDowngrade
Nov 17Hold$2.70
Ascendiant CapitalTarget raised
Sep 30Buy$14.50 → $15
Ascendiant CapitalMaintained
Jun 11Buy$14.50
Date
Firm
Action
Rating
Price target
Nov 17
Lake Street
Downgrade
Hold
$2.70
Sep 30
Ascendiant Capital
Target raised
Buy
$14.50 → $15
Jun 11
Ascendiant Capital
Maintained
Buy
$14.50
Loading…
Technical Analysis
AYTU · as of the Nov 17 close · updated after every close
Turning up, overbought
The stock is 28% above its 20 day and 24% above its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 79), overbought. The nearest support is the Pivot S1 at $2.65, and the nearest resistance the Pivot R1 at $2.67.
Short trendBullish
Long trendNeutral
MomentumStrong
StretchOverbought
VolatilityHigh, 6.0%/day
Key levels
$3.0752 week high+15.4%
$2.67Pivot R1+0.4%
$2.66Pivot+0.0%
$2.66Last close
$2.65Pivot S1−0.4%
$2.27200 day average−14.7%
$2.25Swing low (Aug 13)−15.4%
$2.13100 day average−19.9%
$2.0150 day average−24.4%
$1.9220 day average−27.8%
$1.7552 week low−34.2%
Indicators
RSI (14)
78.98
Overbought above 70
Overbought
MACD
0.00
Above its signal line
Bullish
Stochastic
42.8
Middle of its range
Neutral
ADX (14)
19.0
No clear trend
Williams %R
-1.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
513.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+37.8%
Change over 10 sessions
Bullish
ATR (14)
$0.16
Typical daily range, 6.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Turning up, nearing overbought
Short trendBullish
Long trendNeutral
MomentumStrong
StretchNear overbought
VolatilityNormal, 9.6%/day
Key levels
$3.0752 week high+15.4%
$2.67Pivot R1+0.4%
$2.66Pivot+0.0%
$2.66Last close
$2.65Pivot S1−0.4%
$2.27200 day average−14.7%
$2.25Swing low (Aug 13)−15.4%
$2.13100 day average−19.9%
$2.0150 day average−24.4%
$1.9220 day average−27.8%
$1.7552 week low−34.2%
Indicators
RSI (14)
62.61
Strong, overbought above 70
Neutral
MACD
-0.06
Above its signal line
Bullish
Stochastic
36.0
Middle of its range
Neutral
ADX (14)
23.3
Weak trend
Williams %R
-1.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
108.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+33.7%
Change over 10 sessions
Bullish
ATR (14)
$0.26
Typical daily range, 9.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AYTU
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AYTU did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in AYTU in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AYTU is in one of them and how their past AYTU trades turned out.
Aytu BioPharma is a pharmaceutical company based in Denver, Colorado, that markets and sells prescription medicines for central nervous system conditions. Its main product is EXXUA, a treatment for major depressive disorder in adults. The company also sells ADHD medicines, Adzenys and Cotempla, and Karbinal, an antihistamine suspension used to treat allergic conditions. It sells its products mainly through wholesalers and pharmacies.